Part 11 Redux? Comment Period Extension, Meeting Rescheduling Mulled
This article was originally published in The Gray Sheet
FDA is considering reopening the comment period on the electronic records and signatures rule and may reschedule a public meeting to discuss changes, according to agency staff
You may also be interested in...
Public meeting on FDA's regulation of electronic records and signatures will not be rescheduled, following cancellation to observe the passing of former President Ronald Reagan. All comments and presentations should be submitted to docket number 2004N-0133 for FDA's consideration...
GSK creates another partnership centered on its vaccine adjuvant technology, this time with China's Xiamen Innovax.
Lab testing for COVID-19 has risen to a new high of 314,000 tests per week in Germany, where the concerns are perhaps less about test availability than staff numbers to oversee the testing protocols.